Ozempic-style drugs now in trials for heart failure, addiction and even aging
Examines the potential effects of GLP-1 agonists beyond obesity treatment, including on various conditions like heart failure, addiction, and aging.
Hacker News submitter: randycupertino
Submitted to Hacker News: